1686070900
- Increased frequency of the PTPN22W* variant in primary Sjogren's Syndrome: Association with low type I IFN scores. Nikolaos I. Vlachogiannis a, Adrianos Nezos a, Athanasios G. Tzioufas b,c, Michael Koutsilieris a, Haralampos M. Moutsopoulos b,c, Clio P.Mavragani a,b,c. https://doi.org/10.1016/j.clim.2016.10.015
- A BAFF Receptor His159Tyr Mutation in Sjogren’s Syndrome–Related Lymphoproliferation. Aristea Papageorgiou,1 Clio P. Mavragani,1 Andrianos Nezos,1 Elias Zintzaras,2, Luca Quartuccio,3 Salvatore De Vita,3 Michael Koutsilieris,1 Athanasios G. Tzioufas,1, Haralampos M. Moutsopoulos,1 and Michael Voulgarelis. ARTHRITIS & RHEUMATOLOGY Vol. 67, No. 10, October 2015, pp 2732–2741 DOI 10.1002/art.39231
- B-cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren’s syndrome. Adrianos Nezos a,1, Aristea Papageorgiou b,1, George Fragoulis b, Dimitrios Ioakeimidis c,Michael Koutsilieris a, Athanasios G. Tzioufas b, Haralampos M. Moutsopoulos b, Michael Voulgarelis b,2, Clio P. Mavragani a,*2. https://doi.org/10.1016/j.jaut.2013.04.005
- Treatment with the first TNF inhibitor in rheumatoid arthritis patients in the Hellenic Registry of Biologic Therapies improves quality of life especially in young patients with better baseline functional status. N. Boubouchairopoulou1, I. Flouri2, A.A. Drosos3, K. Boki4, L. Settas5, D. Zisopoulos6, F.N. Skopouli7, I. Papadopoulos8, A. Iliopoulos9, J. Kyriopoulos1, D.T. Boumpas10, K. Athanasakis1, P. Sidiropoulos2. Clin Exp Rheumatol. 2016 Nov-Dec;34(6):999-1005. Epub 2016 Oct 7
- Neuropsychiatric lupus or not? Cerebral hypoperfusion by perfusion-weighted MRI in normal-appearing white matter in primary neuropsychiatric lupus erythematosus. Efrosini Papadaki,1,2 Antonis Fanouriakis,3,4 Eleftherios Kavroulakis,1 Dimitra Karageorgou,1 Prodromos Sidiropoulos,3 George Bertsias,3,5 Panagiotis Simos,2,6 Dimitrios T Boumpas4,5,7,8,9. http://dx.doi.org/10.1136/annrheumdis-2017-212285
